Artificial Intelligence in Pharmaceutical Supply Chain Management

Artificial Intelligence (AI) has emerged as a transformative force in pharmaceutical supply chain management (PSCM), offering innovative solutions to some of the most persistent challenges in the field. This article presents a comprehensive review of the role of AI in reshaping pharmaceutical logistics and supply operations. The introduction outlines the importance of a resilient, responsive, and efficient supply chain in the pharmaceutical industry—where product integrity, timely delivery, and regulatory compliance are critical. The second section delves into the core applications of AI in PSCM, including demand forecasting through predictive analytics, inventory management using machine learning algorithms, automated quality control, route optimization in distribution, and supplier risk assessment. These applications are increasingly used to ensure real-time visibility, minimize wastage, and optimize the end-to-end movement of pharmaceutical products, including temperature-sensitive drugs. The article further discusses the key benefits of adopting AI in this domain. These include enhanced operational efficiency, reduced lead times, cost optimization, data-driven decision-making, improved accuracy in order fulfillment, and greater adaptability to market fluctuations. AI systems enable dynamic forecasting, automate manual processes, and ensure better alignment between production and demand. Despite its advantages, the article also critically evaluates the limitations and challenges associated with AI integration in PSCM. Barriers such as high initial investment, lack of technical expertise, data security and privacy issues, and resistance to change within traditional systems are explored in depth. Moreover, the dependency on high-quality data and the complexity of AI algorithm training are highlighted as significant constraints. In the final section, the article outlines the future scope of AI in pharmaceutical supply chains. With continued technological advancements, the integration of AI with other emerging technologies such as blockchain for traceability, IoT for real-time monitoring, and robotics for warehouse automation promises to redefine PSCM further. Additionally, the adoption of digital twins and autonomous supply networks is expected to enable even more proactive and predictive supply chain operations. Overall, this review emphasizes the growing importance of AI as a strategic enabler in building an agile, intelligent, and patient-centric pharmaceutical supply chain. As the industry evolves, AI will play a pivotal role in enhancing drug availability, ensuring regulatory compliance, and improving global healthcare outcomes.